About CCRM
Commercializing Living Therapies
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Toronto, Ontario
- Founded
- 2011
- Company type
- Nonprofit
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today.
Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011.
CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.
Specialties
- Commercialization
- Cell Reprogramming
- Cell Manufacturing
- Biomaterials + Tissue Mimetics
- Integration of Science + Business
- Industry Consortium
- and Contract Services
Company locations
MaRS Centre, West Tower, 661 University Ave., Suite 1002, Toronto, Ontario M5G 1M1, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 29,951
- People linked to this company
- 206
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.